Sunshine Biopharma Inc expected to post a loss of 37 cents a share - Earnings Preview

Sunshine Biopharma

07/08/2024 16:51

* Sunshine Biopharma Inc  SBFM.OQ   SBFM.O  is expected
to report
resultson August 9 (estimated) for the period ending June
30 2024
    * The Fort Lauderdale Florida-based  company is expected to
report
revenue of $9 million, according to the estimate from one
analyst, based on LSEG data.
    * ​LSEG's mean analyst estimate for Sunshine Biopharma Inc
is for
a loss of 37 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Sunshine
Biopharma Inc is $15.00​, above​ its last closing price
of $0.18. ​​​

This summary was machine generated August 7 at 15:51 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)